Honey Bee, Allergen IgE
Test Codes
EPIC: LAB1230747, Beaker: EHBEE, CHW: LAB1230747
Department
Send Outs
Instructions
Specimens for insect venom and drugs should be drawn at least 2-3 weeks but not longer than 6 months after exposure.
Specimen Collection Criteria
Collect: One Gold-top SST tube.
Physician Office/Draw Specimen Preparation
Let specimen clot for 30 minutes then centrifuge
to separate serum from cells. Transfer serum to plastic transport tube and
maintain at refrigerate (2-8°C or 36-46) prior to transport.
Preparation for Courier Transport
Transport: 3.0 mL serum, refrigerated at (2-8°C or 36-46°F). (Minimum: 2.0 mL)
Rejection Criteria
Specimens not collected and processed as indicated.
In-Lab Processing
Let specimen clot for 30 minutes then centrifuge
to separate serum from cells. Transfer serum to plastic transport tube and
maintain refrigerated at (2-8°C or 36-46) prior to transport.
Transport: 3.0 mL serum, refrigerated at (2-8°C or 36-46°F). (Minimum: 2.0 mL)
Storage
Specimen Stability for Testing:
Room Temperature (20-26°C or 68-78.8°F): 12 hours
Refrigerated (2-8°C or 36-46°F): 7 days
Frozen (-20°C/-4°F or below): Aliquot for longer storage than 7 days.
Specimen Storage in Department Prior to Disposal: 30 days
Specimen retention time is determined by the policy of the reference laboratory. Contact the Send Outs Laboratory with any questions.
Laboratory
Sent to Corewell Health Reference Laboratory,
Grand Rapids, MI.
Performed
Monday – Friday.
Results available in 1-3 days.
Reference Range
<0.35 kU/L
Test Methodology
ImmunoCAP® System Fluorescence Enzyme Immunoassay (FEIA)
Clinical Utility
Honeybee venom allergens included in this panel are: Api m 1, Api m 2, Api m 3, Api m 5, and Api m 10.
Venom allergy diagnosis is supported by detection of sIgE antibodies using whole extracts or individual allergenic venom proteins. Identifying sIgE responses to specific molecular targets with component resolved diagnostics (CRD) helps fine-tune the diagnosis by distinguishing species-specific, co-reactive, or cross-reactive sensitizations. An accurate diagnosis, in turn, facilitates treatment, including prescription of venom immunotherapy (VIT).

Clinical Disease
In the United States it is estimated that one to two million people are severely allergic to stinging insect venoms. Approximately 90 to 100 deaths occur annually from sting reactions. This number may under-represent the true total because some sting reactions are misdiagnosed as heart attacks, sunstrokes, or other acute illnesses. Death can occur without a previous history of a sting allergy. The frequency of fatal reactions due to anaphylaxis increases with age.
Prophylactic measures must be taken for those individuals who develop severe reactions to insect stings. Specific immunotherapy (hyposensitization) remains the most effective means of treatment with a 96% success rate (1).
Reference
- Kaplan, Allen P. M.D. Allergy. Churchill Livingstone: New York, pg. 508-509, 1985.
CPT Codes
86008
Contacts
Send Outs Laboratory – RO
248-551-9045
Name: Send Outs Laboratory – RO
Location:
Phone: 248-551-9045
Last Updated
4/1/2026
Microtainer® and Vacutainer® are registered trademarks of Becton, Dickinson and Company.
UroVysion® is a registered trademark of Abbott Laboratories. ThinPrep® is a registered trademark of Hologic, Incorporated.